PRINCIPAL FINANCIAL GROUP INC - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 190 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRINCIPAL FINANCIAL GROUP INC ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$6,754,821
-13.5%
577,829
-0.5%
0.01%0.0%
Q2 2023$7,808,505
-23.2%
580,990
-5.3%
0.01%
-28.6%
Q1 2023$10,171,813
-13.5%
613,499
-2.9%
0.01%
-22.2%
Q4 2022$11,755,683
+50.7%
632,026
+3.9%
0.01%
+50.0%
Q3 2022$7,803,000
+1424.0%
608,167
+733.2%
0.01%
Q2 2022$512,000
-21.6%
72,996
-7.4%
0.00%
Q1 2022$653,000
-18.7%
78,804
-33.6%
0.00%
Q4 2021$803,000
+1154.7%
118,680
+959.2%
0.00%
Q2 2021$64,000
-32.6%
11,205
-45.9%
0.00%
Q1 2021$95,000
+9.2%
20,701
-20.6%
0.00%
Q4 2020$87,000
-18.7%
26,082
-27.9%
0.00%
Q3 2020$107,000
-39.2%
36,188
-4.9%
0.00%
Q2 2020$176,000
+66.0%
38,038
+38.2%
0.00%
Q1 2020$106,000
+1.0%
27,521
-2.0%
0.00%
Q4 2019$105,000
-33.5%
28,088
-5.7%
0.00%
Q3 2019$158,000
+47.7%
29,801
+7.6%
0.00%
Q2 2019$107,000
+62.1%
27,697
+113.1%
0.00%
Q1 2019$66,000
+135.7%
12,997
-12.0%
0.00%
Q4 2018$28,000
-59.4%
14,763
-19.7%
0.00%
Q3 2018$69,000
+53.3%
18,378
+27.7%
0.00%
Q2 2018$45,000
+2.3%
14,387
+28.2%
0.00%
Q4 2017$44,000
+57.1%
11,2200.0%0.00%
Q3 2017$28,000
-22.2%
11,220
-14.3%
0.00%
Q2 2017$36,000
+140.0%
13,094
+2.7%
0.00%
Q1 2016$15,000
-51.6%
12,7450.0%0.00%
Q4 2015$31,000
-18.4%
12,7450.0%0.00%
Q3 2015$38,00012,7450.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 148,281$2,4587.14%
GABLES CAPITAL MANAGEMENT INC. 409,080$6,782,5464.74%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 10,355,099$171,687,5413.83%
JW Asset Management, LLC 563,392$9,341,0393.58%
Quantedge Capital Pte Ltd 324,700$5,383,5262.10%
Paradiem, LLC 236,628$3,923,2921.22%
SummerHaven Investment Management, LLC 100,592$1,667,8150.97%
Capital Impact Advisors, LLC 46,096$764,2720.94%
Yorktown Management & Research Co Inc 50,000$829,0000.89%
Seaport Global Advisors, LLC 15,598$258,6150.82%
View complete list of CATALYST PHARMACEUTICALS INC shareholders